Synapse - Carol Aghajanian

Search Within

Carol A Aghajanian

Results (615)

Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Journal Article

Monk, B. J.; Sill, M. W.; Walker, J. L.; Darus, C. J.; Sutton, G.; Tewari, K. S.; Martin, L. P.; Schilder, J. M.; Coleman, R. L.; Balkissoon, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

Journal Article

Mueller, J. J.; Zhou, Q. C.; Iasonos, A.; O'Cearbhaill, R. E.; Alvi, F. A.; El Haraki, A.; Eriksson, A. G. Z.; Gardner, G. J.; Sonoda, Y.; Levine, D. A.; more...
Gynecologic Oncology (2016)

Fulltext@MSK | Save

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

Journal Article

Domchek, S. M.; Aghajanian, C.; Shapira-Frommer, R.; Schmutzler, R. K.; Audeh, M. W.; Friedlander, M.; Balmana, J.; Mitchell, G.; Fried, G.; Stemmer, S. M.; more...
Gynecologic Oncology (2016)

Fulltext@MSK | Save

A phase 2, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer

Journal Article

Bell-McGuinn, K. M.; Konner, J. A.; Tew, W. P.; Hensley, M. L.; Iasonos, A.; Charpentier, E.; Mironov, S.; Sabbatini, P.; Aghajanian, C.
International Journal of Gynecological Cancer (2016)

Fulltext@MSK | Save

A systematic review of ovarian cancer and fear of recurrence

Journal Article

Ozga, M.; Aghajanian, C.; Myers-Virtue, S.; McDonnell, G.; Jhanwar, S.; Hichenberg, S.; Sulimanoff, I.
Palliative and Supportive Care (2015)

Fulltext@MSK | Save

Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort

Meeting Abstract

Matulonis, U. A.; Wulf, G.; Barry, W.; Birrer, M.; Westin, S.; Spagnoletti, T.; Bell-McGuinn, K.; Obermayer, E.; Whalen, C.; Aghajanian, C.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Ovarian clear cell carcinoma, outcomes by stage: The MSK experience

Journal Article

Shu, C. A.; Zhou, Q.; Jotwani, A. R.; Iasonos, A.; Leitao, M. M. Jr; Konner, J. A.; Aghajanian, C. A.
Gynecologic Oncology (2015)

Fulltext@MSK | Save

Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer

Journal Article

Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Re-treating with carboplatin and paclitaxel as first line therapy for recurrent endometrial cancer in patients who have previously received this regimen in the adjuvant setting

Meeting Abstract

Cadoo, K.; Halpenny, D.; Phillips, M.; Aghajanian, C.
European Journal of Cancer (2015)

Fulltext@MSK | Save

VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase 1 data by the gynecologic oncology group

Meeting Abstract

Monk, B. J.; Brady, W. E.; Lankes, H. A.; Facciabene, A.; Manjarrez, K. L.; Hershberg, R. M.; Fracasso, P. M.; Bell-Mcguinn, K. M.; Walker, J. L.; McCourt, C. K.; more...
Clinical Cancer Research (2015)

Fulltext@MSK | Save